Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors
Articolo
Data di Pubblicazione:
2016
Abstract:
The role of chemotherapy in low-/intermediate-grade neuroendocrine tumors (NETs) is still debated. We present the results of an Italian multicenter retrospective study evaluating activity and toxicity of oxaliplatin-based chemotherapy in patients with advanced NETs.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Factors; Colorectal Neoplasms; DNA-Binding Proteins; Endonucleases; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome
Elenco autori:
Spada, Francesca; Antonuzzo, Lorenzo; Marconcini, Riccardo; Radice, Davide; Antonuzzo, Andrea; Ricci, Sergio; Di Costanzo, Francesco; Fontana, Annalisa; Gelsomino, Fabio; Luppi, Gabriele; Nobili, Elisabetta; Galdy, Salvatore; Cella, Chiara Alessandra; Sonzogni, Angelica; Pisa, Eleonora; Barberis, Massimo; Fazio, Nicola
Link alla scheda completa:
Pubblicato in: